Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms, Germ Cell and Embryonal × Filgrastim × Clear all

Phase

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Myelodysplastic Syndromes 4 Leukemia, Biphenotypic, Acute 4 Hodgkin Disease 4 Hematologic Neoplasms 4 Leukemia, Myelomonocytic, Chronic 3 Anemia, Refractory, with Excess of Blasts 3 Rhabdomyosarcoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Glioblastoma 2 Burkitt Lymphoma 2 Teratoma 1 Sarcoma, Ewing 1 Sarcoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Multiple Myeloma 1 Medulloblastoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1

Interventions

Etoposide 4 Cisplatin 4 lutetium Lu 177 dotatate 2 fludarabine phosphate 2 fludarabine 2 Cyclophosphamide 2 Bleomycin 2 repotrectinib 1 pegfilgrastim 1 etoposide phosphate 1 copper dotatate CU-64 1 Teniposide 1 Surveys and Questionnaires 1 Standard of Care 1 Specimen Handling 1 Respiratory Physiological Phenomena 1 Practice Guidelines as Topic 1 Platinum 1 Mesna 1 Magnetic Resonance Spectroscopy 1 Lutetium-177 1 Lutetium 1 Injections 1 Infusions, Intravenous 1 Filgrastim 1 Drug Therapy 1 Carboplatin 1 Biopsy 1 Automobiles 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02582697 2025-06-15

P3BEP

University of Sydney

Phase 3 Recruiting

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡